Latest filing published 07 Jul 2026 for BriaCell Therapeutics Corp..
Insider track record
No signal scores available.
Vaughn Embro-Pantalony: trading record in brief
Vaughn Embro-Pantalony appears in our data through filings on BriaCell Therapeutics Corp. shares, published by SEC (Form 4). In total, 9 filings cover trades dated from 15 March 2019 to 7 July 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 7 July 2026, reports a share grant in BriaCell Therapeutics Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Vaughn Embro-Pantalony
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 45,000 sharesRestricted Share UnitsTSXSEDI:4748048
- 574 sharesCommon SharesTSXSEDI:4566590
- 8,889 sharesCommon SharesTSXSEDI:4442956
- 1,423,809 sharesCommon SharesTSXSEDI:3765646
- Common SharesTSXSEDI:3765638
- 1,428,571 shares@ CA$0.07Common SharesTSXSEDI:3765642
- 1,423,809 sharesCommon SharesTSXSEDI:3476532
- 1,428,571 shares@ CA$0.07100.0% of flowCommon SharesTSXSEDI:3423533
- Common SharesTSXSEDI:3423532
9 of 9 declarations
